Indivior Posts Record Q3: SUBLOCADE Up 22%, Adjusted EBITDA Margin Hits 59%
INDV sits 42% above its 52-week low of $24.28.
Summary
Indivior delivered record Q3 2026 results with total net revenue of $356 million, up 13% year-over-year, and SUBLOCADE net revenue of $267 million, up 22%. Adjusted EBITDA jumped 76% to $211 million, a 59% margin, up 2,100 basis points, while GAAP diluted EPS came in at $1.12 versus $0.33 a year ago. Operating expenses fell 33% to $125 million as the Indivior Action Agenda cost cuts took hold, and cash plus investments reached $332 million. The company reaffirmed its standalone FY2026 guidance of $1,295 million to $1,365 million in net revenue and $700 million to $740 million in adjusted EBITDA, though that guidance stops applying once the Supernus merger closes. That merger, approved by shareholders in October, is expected to close November 2, 2026, with the combined company trading as SUPN beginning November 3 — the special dividend of $8.13 per share is contingent on that closing.
At the time of this announcement, INDV was trading at $34.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $24.28 to $42.81. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.